1. Food and Drug Administration. Guidance for industry: oversight of clinical investigations—a risk-based approach to monitoring. http://www.fda.gov/downloads/Drugs/…/Guidances/UCM269919.pdf. Published August 2013. Accessed on November 09, 2014.
2. European Medicines Agency. Reflection paper on risk based quality management in clinical trials. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/11/WC500155491.pdf. Published November 2013. Accessed November 9, 2014.
3. Helfgott J. Risk-based monitoring—regulatory expectations. https://diahome.webex.com/. DIA webinar presented on May 15, 2014.
4. Meehan L. http://polarisconsultants.blogspot.com. Blog posted November 5, 2013.
5. Lee J, Bajpai A, Carnan E, et al. Shifting monitoring paradigms: challenges and opportunities. Appl Clin Trials. 2014;23(6).